Noninvasive diagnostic can help federal medical system address veterans at higher risk for developing lung cancer

U.S. Medicine, a leading publication for federal healthcare professionals, has featured bioAffinity Technologies' CyPath® Lung in its pulmonary issue, highlighting the test's potential to improve lung cancer detection while lowering costs for the Department of Veterans Affairs (VA).

• No comments yet. Be the first to comment!